S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

AMPH Amphastar Pharmaceuticals Inc

39.14

-0.25 (-0.63%)

Dec 20 2024 - Closed

Delayed by 15 minutes

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Amphastar Pharmaceuticals (NASDAQ:AMPH)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more Amphastar Pharmaceuticals Charts.

Amphastar Pharmaceuticals (NASDAQ:AMPH)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more Amphastar Pharmaceuticals Charts.

Amphastar Pharmaceuticals Inc News

Form 4 - Statement of changes in beneficial ownership of securities
Monday 16 December 2024 (5 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 13 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 12 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Tuesday 12 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 8 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 7 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Wednesday 6 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 6 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 17 September 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 16 September 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 6 September 2024 (3 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Thursday 5 September 2024 (4 months ago) • Edgar (US Regulatory)

More Amphastar Pharmaceuticals Inc News Articles

Sterling vs SCR

Societe Generale Effekten

Vontobel Financial Produ...

Cousins Properties

FIL Fund Management Irel...

Solactive leveraged long...

Intesa Sanpaolo

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions